Merck prescribes AI for supply chain complexity

Merck KGaA is using artificial intelligence to better understand how its pharmaceutical products, including fertility and oncology drugs, traverse a network of suppliers and partners that is becoming more complex. It's the latest leg in the German company's journey from reacting to changes in the supply chain to predicting them and prescribing corrective actions, says Alessandro De Luca, CIO of Merck's health-care division.

To read this article in full, please click here

(Insider Story)